Holen Sie sich die Stockscreener-App
5.41
10.84%
-0.68
Schlusskurs vom Vortag:
$6.09
Offen:
$6.12
24-Stunden-Volumen:
30,414
Relative Volume:
0.47
Marktkapitalisierung:
$195.45M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-25.50M
KGV:
-7.026
EPS:
-0.77
Netto-Cashflow:
$-30.10M
1W Leistung:
-3.21%
1M Leistung:
-7.18%
6M Leistung:
+35.58%
1J Leistung:
+56.25%
1-Tages-Spanne:
$5.40
$6.25
1-Wochen-Bereich:
$5.33
$6.25
52-Wochen-Spanne:
$2.6801
$7.19
Eupraxia Pharmaceuticals Inc Stock (EPRX) Company Profile
Firmenname
Eupraxia Pharmaceuticals Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie EPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EPRX
Eupraxia Pharmaceuticals Inc
|
5.435 | 308.13M | 0 | -25.50M | -30.10M | -0.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.31 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.37 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.58 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
836.47 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.82 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-06-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-06-16 | Eingeleitet | Canaccord Genuity | Speculative Buy |
| 2025-02-21 | Eingeleitet | Craig Hallum | Buy |
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
Eupraxia Pharmaceuticals Inc Aktie (EPRX) Neueste Nachrichten
Volatility clustering patterns for Eupraxia Pharmaceuticals Inc.Weekly Trade Analysis & Risk Controlled Swing Alerts - newser.com
What MACD signals say about Eupraxia Pharmaceuticals Inc.Weekly Trade Review & Detailed Earnings Play Alerts - newser.com
Eupraxia Pharmaceuticals Inc. stock trend forecastWeekly Trend Summary & AI Powered Market Trend Analysis - newser.com
Is Eupraxia Pharmaceuticals Inc. stock ready for a breakoutWeekly Trading Summary & AI Forecast Swing Trade Picks - newser.com
Is Eupraxia Pharmaceuticals Inc. stock bottoming outTrade Exit Summary & Long Hold Capital Preservation Tips - newser.com
Why Eupraxia Pharmaceuticals Inc. stock is trending among retail tradersTrade Risk Report & Community Verified Swing Trade Signals - newser.com
Can Eupraxia Pharmaceuticals Inc. stock continue upward trendWeekly Loss Report & Reliable Price Breakout Alerts - newser.com
Will Eupraxia Pharmaceuticals Inc. (X43) stock outperform global peersMarket Risk Analysis & Reliable Price Action Trade Plans - newser.com
Is Eupraxia Pharmaceuticals Inc. stock reversal real or fake2025 Trade Ideas & Safe Entry Momentum Stock Tips - newser.com
Using data filters to optimize entry into Eupraxia Pharmaceuticals Inc.2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com
Eupraxia Pharmaceuticals Inc. stock prediction for this weekPortfolio Growth Summary & Community Verified Trade Alerts - newser.com
(EPRX.WT.A) Stock Analysis and Trading Signals - news.stocktradersdaily.com
Will Eupraxia Pharmaceuticals Inc. stock see insider buyingWeekly Loss Report & Weekly Hot Stock Watchlists - newser.com
Is Eupraxia Pharmaceuticals Inc. reversing from oversold territoryNew Guidance & High Accuracy Trade Signal Alerts - newser.com
Regression analysis insights on Eupraxia Pharmaceuticals Inc. performanceJuly 2025 Market Mood & Weekly High Potential Stock Alerts - newser.com
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
(EPRX) Stock Trading Blueprint (EPRX:CA) - news.stocktradersdaily.com
Research Analysts Offer Predictions for EPRX FY2025 Earnings - MarketBeat
Strategies to average down on Eupraxia Pharmaceuticals Inc.July 2025 Earnings & Reliable Trade Execution Plans - newser.com
Eupraxia Pharmaceuticals Inc. (EPRX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Upgraded to Strong-Buy at Leede Financial - MarketBeat
Eupraxia Pharmaceuticals (EPRX) Expected to Announce Earnings on Thursday - MarketBeat
(EPRX.WT.A) Optimized Trading Opportunities - news.stocktradersdaily.com
Eupraxia Pharmaceuticals Inc. (EPRX.TO) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Eupraxia Pharmaceuticals Advances EoE Treatment with EP-104GI Trial - TipRanks
This analyst loves Eupraxia Pharmaceuticals - Cantech Letter
(EPRX) Trading Strategy and Analysis (EPRX:CA) - news.stocktradersdaily.com
Chart based analysis of Eupraxia Pharmaceuticals Inc. trendsWeekly Investment Report & AI Enhanced Trade Execution Alerts - newser.com
Finanzdaten der Eupraxia Pharmaceuticals Inc-Aktie (EPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):